Ticker Details
Pulmonx Corporation
IPO Date:	October 1, 2020
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$62.09M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 3.48%
Avg Daily Range (30 D):	$0.05 | 3.63%
Avg Daily Range (90 D):	$0.06 | 4.12%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	.36M
Avg Daily Volume (90 D):	.46M

Trade Size
Avg Trade Size (Sh.):	98
Avg Trade Size (Sh.) (30 D):	133
Avg Trade Size (Sh.) (90 D):	150

Institutional Trades
Total Institutional Trades:	995
Avg Institutional Trade:	$1.66M
Avg Institutional Trade (30 D):	$3.68M
Avg Institutional Trade (90 D):	$2.29M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.63M
Avg Closing Trade (30 D):	$3.68M
Avg Closing Trade (90 D):	$3.68M
Avg Closing Volume:	74.13K

News

Jun 24, 2024 @ 12:16 PM 5 Medical Info Systems Stock to Buy for a Stable P... Source: Nalak Das

May 22, 2024 @ 1:55 PM How Much Upside is Left in Pulmonx (LUNG)? Wall St... Source: Zacks Equity Research

May 10, 2024 @ 12:29 PM 5 Medical Info Systems Stocks to Buy for Stable Re... Source: Nalak Das

May 6, 2024 @ 9:03 PM Pulmonx Announces Inducement Grants under Nasdaq L... Source: Pulmonx Corporation

May 6, 2024 @ 1:55 PM Wall Street Analysts See a 56.11% Upside in Pulmon... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.33	$-.25	$-1.33
Diluted EPS	$-.33	$-.25	$-1.33
Revenue	$20.59M	$22.6M	$90.5M
Gross Profit	$16.04M	$17.54M	$67.14M
Net Income / Loss	$-13.65M	$-10.43M	$-54M
Operating Income / Loss	$-12.96M	$-9.9M	$-53.66M
Cost of Revenue	$4.54M	$5.06M	$23.36M
Net Cash Flow	$-8.18M	$-6.8M	$-1.15M
PE Ratio